The Global Alliance for Transplantation
- The Global Alliance for Transplantation
- 1. Introduction
- 2. Goals and major strategic directions
- 3. Proposed Structure and Governance of the Alliance
- 4. Relationships to other organisations and associations
- 5. Relationships to the Pharmaceutical industry
- 6. Strategic Directions
- 7. Implementation Timetable
- All Pages
Organ transplantation is a successful therapy for end stage organ failure of the kidney, liver, heart, lung, pancreas and intestine. Transplantation of cells and tissues has also transformed the therapeutic options for patients with malignant haematological disease, eye disease and orthopaedic disease, and has the potential to alter significantly the therapeutic options for patients with diabetes and a range of disorders.
The access of patients to transplantation therapy varies widely across the globe, partly determined by the underlying level of economic development in different states and partly determined by other factors such as the availability of organ, cell and tissue donors, or the specialist provision of health services.
The Transplantation Society has determined that it will seek to address global inequities in transplantation therapy, in order to facilitate appropriate access to transplantation for all patients who would benefit.
Table – Transplantation of organs in different continents/regions year 2000
|*Per million population|